Comments regarding 'A randomised placebo-controlled double-blind trial to evaluate lipid-lowering pharmacotherapy on proteolysis and inflammation in abdominal aortic aneurysms'

Eur J Vasc Endovasc Surg. 2011 Jan;41(1):36-7. doi: 10.1016/j.ejvs.2010.09.023. Epub 2010 Oct 18.

Author

M Vega de Céniga¹

Affiliation

¹ Department of Angiology and Vascular Surgery, Hospital de Galdakao-Usansolo, Barrio Labeaga s/n, 48960 Galdakao, Bizkaia, Spain.

PMID: 20961777
DOI: 10.1016/j.ejvs.2010.09.023

No abstract available

Publication types

Comment

MeSH terms

Anticholesteremic Agents / therapeutic use*
Aorta, Abdominal / metabolism*
Aorta, Abdominal / pathology
Aorta, Abdominal / surgery
Aortic Aneurysm, Abdominal / therapy*
Azetidines / therapeutic use
Biopsy
Drug Therapy, Combination
Ezetimibe
Humans
Interleukin-6 / metabolism*
Matrix Metalloproteinase 9 / metabolism*
Randomized Controlled Trials as Topic*
Simvastatin / therapeutic use

Substances

Anticholesteremic Agents
Azetidines
Interleukin-6
Simvastatin
Matrix Metalloproteinase 9
Ezetimibe